Werewolf Therapeutics Inc (HOWL)

[Monksdream]

HOWL under $10

[Monksdream]

HOWL new 52 week high

[Pt3]

Yea your gap and trapped make me buy caud instead of this

[TheFinalCD]

HOWL todays algo patented Gap & Trap on Phase #1 news

[TheFinalCD]

Werewolf Therapeutics soars 52% premarket after presentsing preliminary monotherapy data from Phase 1/1b clinical trial establishing proof of mechanism for WTX-124$HOWL#AInvest #Ainvest_Wire #trade #source #wallstreet
View more: https://t.co/aTzfU7GqUS pic.twitter.com/rClSWzl2IS

— AInvest Wire (@Ainvest_Wire) November 3, 2023

[TheFinalCD]

$howl flying https://finviz.com/quote.ashx?t=HOWL&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/HOWL

[tw0122]

$3 + otw Halloween is here give it a HOWL

[The Night Stalker]

https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

[The Night Stalker]

https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

[The Night Stalker]

dip

[The Night Stalker]

dip

[The Night Stalker]

watching

[The Night Stalker]

soon

[The Night Stalker]

insert dd

[The Night Stalker]

can be big

[The Night Stalker]

wow

[The Night Stalker]

wow

[The Night Stalker]

hold

[The Night Stalker]

slow

[The Night Stalker]

slow

[The Night Stalker]

agreed

[The Night Stalker]

like thiks

[The Night Stalker]

off radar

[The Night Stalker]

catchy name

[The Night Stalker]

catchy name

[surf1944]

https://stockcharts.com/h-sc/ui?s=howl&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/howl/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/howl/opinion

[Mr. Zen]

Watch list addition, this has the potential to run, just waiting for all the pieces of the puzzle to come together.

“These promising preclinical data add to a growing body of evidence demonstrating the potential of WTX-330 to drive targeted anti-tumor immune responses selectively in the tumor microenvironment (TME),” said Cynthia Seidel-Dugan, Ph.D., Chief Scientific Officer of Werewolf Therapeutics. “This morning, in our Third Quarter 2022 release, we announced that the FDA has granted clearance of the investigational new drug (IND) application for WTX-330. We are excited to advance WTX-330 into the clinic and to continue developing a pipeline of novel proinflammatory cytokine therapies that have the potential to change the lives of cancer patients.”

[makinezmoney]

$HOWL: Hey thanks....... now 3.20.

Only getting better right ??


Enjoy those profits.





GO $HOWL

[Makk1]

Good call here, looking very good

[makinezmoney]

$HOWL: Looks like its turning...... now 2.25

Let see if volume pushes it up.


The setup is nice


GO $HOWL

[bobbo5]

I agree and it looks like share price has been moving up this past week

[dia76ca]

Very interesting company. I like it's chances.